Herbst RS , Baas P , Kim DW , Felip E , Pérez -Gracia JL , Han JY , et al. Pembrolizumab versus docetaxel for previou sly treated, PD -L1-positive, advanced non -small -cell lung cancer (KEYNOTE -010): a randomised controlled trial. Lancet.